Table of Contents

Executive Summary

1 Industry Overview of Serum Biomarkers

• 1.1 Definition of Serum Biomarkers
• 1.2 Serum Biomarkers Segment by Type
  • 1.2.1 Global Serum Biomarkers Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Hepatocellular Carcinoma Serum Biomarkers
  • 1.2.3 Lung Cancer Serum Biomarkers
  • 1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
  • 1.2.5 Breast Cancer Serum Biomarkers
  • 1.2.6 Glioblastoma Serum Biomarkers
  • 1.2.7 Others
• 1.3 Serum Biomarkers Segment by Applications
  • 1.3.1 Global Serum Biomarkers Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Academic & Research Institutes
  • 1.3.4 Ambulatory Surgical Centers
  • 1.3.5 Others
• 1.4 Global Serum Biomarkers Overall Market
  • 1.4.1 Global Serum Biomarkers Revenue (2014-2025)
  • 1.4.2 Global Serum Biomarkers Production (2014-2025)
  • 1.4.3 North America Serum Biomarkers Status and Prospect (2014-2025)
  • 1.4.4 Europe Serum Biomarkers Status and Prospect (2014-2025)
  • 1.4.5 China Serum Biomarkers Status and Prospect (2014-2025)
  • 1.4.6 Japan Serum Biomarkers Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Serum Biomarkers Status and Prospect (2014-2025)
  • 1.4.8 India Serum Biomarkers Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Serum Biomarkers
• 2.3 Manufacturing Process Analysis of Serum Biomarkers
• 2.4 Industry Chain Structure of Serum Biomarkers

3 Development and Manufacturing Plants Analysis of Serum Biomarkers

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Serum Biomarkers Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Serum Biomarkers
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Serum Biomarkers Production and Capacity Analysis
• 4.2 Serum Biomarkers Revenue Analysis
• 4.3 Serum Biomarkers Price Analysis
• 4.4 Market Concentration Degree

5 Serum Biomarkers Regional Market Analysis

• 5.1 Serum Biomarkers Production by Regions
  • 5.1.1 Global Serum Biomarkers Production by Regions
  • 5.1.2 Global Serum Biomarkers Revenue by Regions
• 5.2 Serum Biomarkers Consumption by Regions
• 5.3 North America Serum Biomarkers Market Analysis
  • 5.3.1 North America Serum Biomarkers Production
  • 5.3.2 North America Serum Biomarkers Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Serum Biomarkers Import and Export
• 5.4 Europe Serum Biomarkers Market Analysis
  • 5.4.1 Europe Serum Biomarkers Production
  • 5.4.2 Europe Serum Biomarkers Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Serum Biomarkers Import and Export
• 5.5 China Serum Biomarkers Market Analysis
  • 5.5.1 China Serum Biomarkers Production
  • 5.5.2 China Serum Biomarkers Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Serum Biomarkers Import and Export
• 5.6 Japan Serum Biomarkers Market Analysis
  • 5.6.1 Japan Serum Biomarkers Production
  • 5.6.2 Japan Serum Biomarkers Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Serum Biomarkers Import and Export
• 5.7 Southeast Asia Serum Biomarkers Market Analysis
  • 5.7.1 Southeast Asia Serum Biomarkers Production
  • 5.7.2 Southeast Asia Serum Biomarkers Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Serum Biomarkers Import and Export
• 5.8 India Serum Biomarkers Market Analysis
  • 5.8.1 India Serum Biomarkers Production
  • 5.8.2 India Serum Biomarkers Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Serum Biomarkers Import and Export

6 Serum Biomarkers Segment Market Analysis (by Type)

• 6.1 Global Serum Biomarkers Production by Type
• 6.2 Global Serum Biomarkers Revenue by Type
• 6.3 Serum Biomarkers Price by Type

7 Serum Biomarkers Segment Market Analysis (by Application)

• 7.1 Global Serum Biomarkers Consumption by Application
• 7.2 Global Serum Biomarkers Consumption Market Share by Application (2014-2019)

8 Serum Biomarkers Major Manufacturers Analysis

• 8.1 Roche
  • 8.1.1 Roche Serum Biomarkers Production Sites and Area Served
  • 8.1.2 Roche Product Introduction, Application and Specification
  • 8.1.3 Roche Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Pfizer
  • 8.2.1 Pfizer Serum Biomarkers Production Sites and Area Served
  • 8.2.2 Pfizer Product Introduction, Application and Specification
  • 8.2.3 Pfizer Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Novartis
  • 8.3.1 Novartis Serum Biomarkers Production Sites and Area Served
  • 8.3.2 Novartis Product Introduction, Application and Specification
  • 8.3.3 Novartis Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Abbott
  • 8.4.1 Abbott Serum Biomarkers Production Sites and Area Served
  • 8.4.2 Abbott Product Introduction, Application and Specification
  • 8.4.3 Abbott Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 BD
  • 8.5.1 BD Serum Biomarkers Production Sites and Area Served
  • 8.5.2 BD Product Introduction, Application and Specification
  • 8.5.3 BD Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Merck
  • 8.6.1 Merck Serum Biomarkers Production Sites and Area Served
  • 8.6.2 Merck Product Introduction, Application and Specification
  • 8.6.3 Merck Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Eli Lilly
  • 8.7.1 Eli Lilly Serum Biomarkers Production Sites and Area Served
  • 8.7.2 Eli Lilly Product Introduction, Application and Specification
  • 8.7.3 Eli Lilly Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Agilent Technologies
  • 8.8.1 Agilent Technologies Serum Biomarkers Production Sites and Area Served
  • 8.8.2 Agilent Technologies Product Introduction, Application and Specification
  • 8.8.3 Agilent Technologies Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Boehringer Ingelheim
  • 8.9.1 Boehringer Ingelheim Serum Biomarkers Production Sites and Area Served
  • 8.9.2 Boehringer Ingelheim Product Introduction, Application and Specification
  • 8.9.3 Boehringer Ingelheim Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 AstraZeneca
  • 8.10.1 AstraZeneca Serum Biomarkers Production Sites and Area Served
  • 8.10.2 AstraZeneca Product Introduction, Application and Specification
  • 8.10.3 AstraZeneca Serum Biomarkers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Bristol-Myers Squibb
• 8.12 Novo Nordisk
• 8.13 Allergan
• 8.14 Gilead

9 Development Trend of Analysis of Serum Biomarkers Market

• 9.1 Global Serum Biomarkers Market Trend Analysis
  • 9.1.1 Global Serum Biomarkers Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Serum Biomarkers Regional Market Trend
  • 9.2.1 North America Serum Biomarkers Forecast 2019-2025
  • 9.2.2 Europe Serum Biomarkers Forecast 2019-2025
  • 9.2.3 China Serum Biomarkers Forecast 2019-2025
  • 9.2.4 Japan Serum Biomarkers Forecast 2019-2025
  • 9.2.5 Southeast Asia Serum Biomarkers Forecast 2019-2025
  • 9.2.6 India Serum Biomarkers Forecast 2019-2025
• 9.3 Serum Biomarkers Market Trend (Product Type)
• 9.4 Serum Biomarkers Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Serum Biomarkers Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
The global serum biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.

The global Serum Biomarkers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Serum Biomarkers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Serum Biomarkers market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Serum Biomarkers in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Serum Biomarkers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others

Segment by Application
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others